Overview

Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This study will provide the clinicians guidance on the safest combination of inhaled and nasal corticosteroids for children with mild asthma and allergic rhinitis respectively; however, one safety concern is that these products are independently known to have dose-related effects on short term and intermediate term growth. Knemometry is a non invasive technique for measuring short-term lower leg growth in children and is currently the method of choice in growth studies of short duration. Subjects will be seen on a weekly basis for 18 weeks and at each visit, lower leg length will be measured using knemometry.
Phase:
Phase 4
Details
Lead Sponsor:
West Penn Allegheny Health System
Treatments:
Beclomethasone
Ciclesonide